MARKET

LABD

LABD

Direxion Daily S&P Biotech Bear 3X Etf
NYSEARCA

Real-time Quotes | Provided by Morningstar

61.29
+6.45
+11.76%
After Hours: 61.30 +0.01 +0.02% 16:37 05/24 EDT
OPEN
57.03
PREV CLOSE
54.84
HIGH
62.39
LOW
56.50
VOLUME
3.45M
TURNOVER
0
52 WEEK HIGH
85.28
52 WEEK LOW
16.67
TOTAL ASSET
69.82M
YTD YIELD
-70.39%
1D
5D
1M
3M
1Y
5Y
Barclays Warns Even Fully Collateralized Stablecoins May Be Prone to Downwards Spiral 
Bloomberg · 5d ago
FTX US Offers Trading of Old-School Stocks as Crypto Backstop
Bloomberg · 5d ago
Software Stocks Pummeled Even Harder Than Rest of Tech Market
Bloomberg · 6d ago
Buying Call Options Is New Stock Hedge for Traders Eyeing a Big Bounce
Bloomberg · 05/17 20:05
Investors Who Shorted Russia ETFs Are Now Stuck Paying Never-Ending Fees
Bloomberg · 05/17 12:03
Cathie Wood Just Keeps Buying Coinbase and Getting More Inflows
Bloomberg · 05/14 17:00
Cliff Asness Takes a Swipe at ARK: ‘We Were Right, You Are Not’
Bloomberg · 05/12 19:47
Wood’s ARKK Is Epicenter of Market Rout as ETF Nears Covid Low
Bloomberg · 05/12 12:47
More
No Data
Learn about the latest financial forecast of LABD. Analyze the recent business situations of Direxion Daily S&P Biotech Bear 3X Etf through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
Ratings
Date
Period
Agency
Ratings
04/30/2022
3 Year
Lipper Fund
04/30/2022
5 Year
Lipper Fund
  • Performance
  • Asset Allocation
  • Dividend History
Period
Return
Rank in Cat
1-Day
82.9400%
--
1-Month
37.0884%
--
3-Month
29.7646%
--
6-Month
143.5705%
--
1-Year
126.3656%
--
3-Year
-88.8025%
--
5-Year
-97.2874%
--
No Data
No Data
No Data
Profile
Fund Name
Direxion Daily S&P Biotech Bear 3X Etf
Inception Date
2015-05-28
Benchmark
Russell 2000 Growth TR
Advisor Company
Rafferty Asset Management LLC
Custodian
Bank of New York Mellon
Manager
Brigandi/Ng